Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Antigenic Properties
Lancefield's group A
Product Format
freeze-dried
Disclosure
This material is cited in a US or other Patent and may not be used to
infringe the claims. Depending on the wishes of the Depositor, ATCC may be
required to inform the Patent Depositor of the party to which the material was
furnished. This material may not have been produced or characterized by ATCC.
Okamoto H, Koshimura S. Treating method of Streptococcus hemolyticus and the preparation containing the said microorganism. US Patent 3,477,914 dated Nov 11 1969
Sotomura M, et al. Method for the treatment of cells of Streptococcus pyogenes. US Patent 4,328,218 dated May 4 1982
Okamoto H, et al. Experimental anticancer studies. Part XXXI. On the streptococcal preparation having potent anticancer activity. Jpn. J. Exp. Med. 36: 175-186, 1966. PubMed: 5297294
Okamoto H, et al. Experimental anticancer studies. Part XXX. Factors influencing the streptolysin S-forming ability of streptococci having anticancer activity. Jpn. J. Exp. Med. 36: 161-174, 1966. PubMed: 5297293
